135
General Jeff Sessions as it was announced on the same day. The deal with Alfred Pedersen & Son will give Aurora the largest funded capacity footprint in the European market, capable of producing 120,000 kg of cannabis per year. The first phase of con-struction is expected to be completed by Q3 2018 (1/5th of the 1 million square foot plan). The joint venture called Aurora Nordic Cannabis will be based out of Denmark and focus on selling cannabis in Nordic countries (Denmark, Sweden, Norway, Finland and Iceland).
Delivering high quality, organic, sustainable CBD from natural hemp strains of cannabis sativa, Eviana Health Corporation Inc. (CSE:EHC) burst onto the market in September 2017, with a license to grow hemp on 130 hectares of “Europe’s most fertile agricultural land” in Serbia. The company is based out of Vancouver. But all operations currently reside in Serbia. In case you haven’t heard of them, the company has an excellent investor’s fact sheet on its website. You can find the link here: Investor Fact Sheet. Some of the key points listed include expectations of $30 million in revenue in its first year of operations, with an EBITDA of $16.5 million ($26-36/g margin at wholesale level and $75-85/g at retail level). The company is currently in discussions with large pharmaceutical companies and Canadian LP’s interested in acquiring its entire CBD production. One can see how interest might be great, given its solid established foothold already in Europe.
ABCann Global Corporation (TSXV:ABCN; OTC:ABCCF; FRA:23Q) has projected international sales revenue to be half of its total $500 million revenue projected by 2021. Having a presence in Germany, Australia and Israel, three of the largest legal markets outside of North America, they are poised to do just that. Well, it is in their name (“ABCann GLOBAL”).
Source: ABCann Global Corporation January 2018 Investor Presentation
General Jeff Sessions as it was announced on the same day. The deal with Alfred Pedersen & Son will give Aurora the largest funded capacity footprint in the European market, capable of producing 120,000 kg of cannabis per year. The first phase of con-struction is expected to be completed by Q3 2018 (1/5th of the 1 million square foot plan). The joint venture called Aurora Nordic Cannabis will be based out of Denmark and focus on selling cannabis in Nordic countries (Denmark, Sweden, Norway, Finland and Iceland).
Delivering high quality, organic, sustainable CBD from natural hemp strains of cannabis sativa, Eviana Health Corporation Inc. (CSE:EHC) burst onto the market in September 2017, with a license to grow hemp on 130 hectares of “Europe’s most fertile agricultural land” in Serbia. The company is based out of Vancouver. But all operations currently reside in Serbia. In case you haven’t heard of them, the company
has an excellent investor’s fact sheet on its website. You can find the link here: Investor Fact Sheet. Some of the key points listed include expectations of $30 million in revenue in its first year of operations, with an EBITDA of $16.5 million ($26-36/g margin at wholesale level and $75-85/g at retail level). The company is currently in discussions with large pharmaceutical companies and Canadian LP’s interested in acquiring its entire CBD production. One can see how interest might be great, given its solid established foothold already in Europe.
ABCann Global Corporation (TSXV:ABCN; OTC:ABCCF; FRA:23Q) has projected international sales revenue to be half of its total $500 million revenue projected by 2021. Having a presence in Germany, Australia and Israel, three of the largest legal markets outside of North America, they are poised to do just that. Well, it is in their name (“ABCann GLOBAL”).